Evidence map›Paper›PMID 27681815›Full record

ArticleInternational journal of cancer2017

Country-specific HPV-related genital disease among men residing in Brazil, Mexico and The United States: The HIM study.

Staci L Sudenga, B Nelson Torres, William J Fulp, Roberto Silva, Luisa L Villa, Eduardo Lazcano-Ponce, Donna J Ingles, Mark Stoler, Jane L Messina, Martha Abrahamsen and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in International journal of cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Comparison of the Natural History of Genital HPV Infection among Men by Country: Brazil, Mexico, and the United States.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Staci L SudengaCenter for Infection Research on Cancer, Moffitt Cancer Center & Research Institute, Tampa, FL.
B Nelson TorresCenter for Infection Research on Cancer, Moffitt Cancer Center & Research Institute, Tampa, FL.
William J FulpCenter for Infection Research on Cancer, Moffitt Cancer Center & Research Institute, Tampa, FL.
Roberto SilvaCentro de Referencia de Treinamento em DST e Aids, São Paulo, Brazil.
Luisa L VillaUniversidade de São Paulo, São Paulo, Brazil.
Eduardo Lazcano-PonceInstituto Nacional de Salud Pública, Cuernavaca, México.
Donna J InglesCenter for Infection Research on Cancer, Moffitt Cancer Center & Research Institute, Tampa, FL.
Mark StolerSchool of Medicine, University of Virginia Health System, Charlottesville, VA.
Jane L MessinaCenter for Infection Research on Cancer, Moffitt Cancer Center & Research Institute, Tampa, FL.
Martha AbrahamsenCenter for Infection Research on Cancer, Moffitt Cancer Center & Research Institute, Tampa, FL.
Maria Luiza BaggioUniversidade de São Paulo, São Paulo, Brazil.
Jorge SalmeronInstituto Nacional de Salud Pública, Cuernavaca, México.
Manuel QuiterioInstituto Nacional de Salud Pública, Cuernavaca, México.
Anna R GiulianoCenter for Infection Research on Cancer, Moffitt Cancer Center & Research Institute, Tampa, FL.
Moffitt Cancer Center · USInstituto Nacional de Salud Pública · MXUniversidade de São Paulo · BRUniversity of Virginia Health System · US

Funding

Natural History of HPV Infection in Men: The HIM StudyR01CA098803 · NCI · H. LEE MOFFITT CANCER CTR &RES INST · PI GIULIANO, ANNA R. · 2004 to 2014
$18.2M
NCI NIH HHS R01 CA098803
6 · The paper itself

Abstract

The purpose of this study was to assess whether the incidence of histopathologically confirmed condyloma and penile intraepithelial neoplasia (PeIN) and rates of genital HPV infection progression to these lesions differs by country (Brazil, Mexico and the U.S.). At each visit, lesions were biopsied and were categorized by pathologic diagnoses. The Linear Array genotyping method was used to identify HPV genotypes from genital swabs, while the INNO-LiPA HPV Genotyping Extra method was used for tissue specimens. Age-specific analyses were conducted for lesion incidence by country, with Kaplan-Meier estimation of cumulative incidence. The proportion of HPV infections that progressed to condyloma and PeIN, the median time to lesion development and the incidence rates were estimated by country. When comparing demographic and sexual characteristics across the three countries, sexual orientation (p = 0.008) and lifetime number of female sexual partners (p < 0.0001) were differentially associated with lesion incidence in the three countries. Condyloma incidence in Brazil and the U.S. decreased with age, while incidence remained constant across the lifespan in Mexico. There were no differences by country and age for PeIN incidence. HPV types 6 and 11 were the most common types to progress to condyloma and HPV types 16, 6 and 11 were the most common types to progress to PeIN in all three countries. The continuous risk of condyloma and PeIN across all age groups and countries in this study emphasizes the need to ensure that strong HPV immunity, such as that obtained through vaccination, is maintained across the lifespan of men.

Indexed as

AdolescentAdultAgedBrazilGenital Diseases, MaleGenotypeHumansIncidenceMaleMexicoMiddle AgedPapillomaviridaePapillomavirus InfectionsRisk FactorsSexual BehaviorSexual Partnerscondylomaexternal genital lesionHIM Studyhuman papillomavirusPeIN

Identifiers

PMID27681815
PMCPMC5687823
OpenAlexW2524962518

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.